Patents Assigned to Aeropharm Technology Limited
  • Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
    Patent number: 5891420
    Abstract: Aerosol formulations for oral inhalation containing triamcinolone acetonide and HFC 134a and/or HFC 227 as a propellant which are free of chlorofluorocarbons and surfactants are disclosed.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: April 6, 1999
    Assignee: Aeropharm Technology Limited
    Inventor: Anthony J. Cutie
  • Environmentally safe flunisolide aerosol formulations for oral inhalation
    Patent number: 5891419
    Abstract: Aerosol formulations for oral inhalation containing flunisolide dispersed in HFC 134a and/or HFC 227 which are free of chlorofluorocarbons and surfactants, and contain little or no ethanol, are disclosed. Metered dose inhalers suitable for delivering such formulations are also disclosed.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: April 6, 1999
    Assignee: Aeropharm Technology Limited
    Inventor: Anthony J. Cutie